论文部分内容阅读
目的:研究在重症哮喘的治疗中给予双水平气道正压无创呼吸机辅助通气治疗的实际价值。方法:选取韶关市第一人民医院2015年4月至2016年3月收治的60例重症哮喘患者,结合临床随机表法将其平均地列入观察组与对照组。对照组行常规对症治疗,观察组在对照组基础上行双水平气道正压无创呼吸机辅助通气治疗。对比两组患者治疗有效率、症状积分以及肺功能情况。结果:观察组的治疗有效率是93.3%,对照组的治疗有效率是73.3%,组间比较差异具有统计学意义(P<0.05);治疗后,两组患者日夜症状评分、肺功能指标比较,差异具有统计学意义(P<0.01)。结论:在重症哮喘的治疗中,双水平气道正压无创呼吸机辅助通气治疗能够有效地改善患者的肺功能,提高治疗有效率。
Objective: To study the practical value of double-level positive airway pressure-assisted ventilation assisted therapy in the treatment of severe asthma. Methods: Sixty patients with severe asthma admitted from April 2015 to March 2016 in First People’s Hospital of Shaoguan were enrolled in the study. Patients were randomly divided into observation group and control group. Control group routine symptomatic treatment, the observation group in the control group based on bi-level positive airway pressure noninvasive ventilator-assisted ventilation. Comparison of two groups of patients treatment efficiency, symptom scores and lung function. Results: The effective rate of treatment was 93.3% in the observation group and 73.3% in the control group, with significant difference between the two groups (P <0.05). After treatment, day and night symptom scores and lung function indexes , The difference was statistically significant (P <0.01). Conclusion: In the treatment of severe asthma, bi-level positive airway pressure noninvasive ventilator-assisted ventilation can effectively improve the patient’s lung function and improve the treatment efficiency.